Revision of Third Quarter 2025 - Unaudited (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Revision of Third Quarter 2025 - Unaudited [Abstract] |
|
| Schedule of Company’s Condensed Consolidated Balance Sheets |
The following tables present the effects of the
aforementioned revisions on the Company’s condensed consolidated balance sheets as of September 30, 2025:
| | |
September 30, 2025 | |
| | |
As previously
reported | | |
Adjustment | | |
As
corrected | |
| Accounts payable | |
$ | 6,982 | | |
$ | (49 | ) | |
$ | 6,933 | |
| Total current liabilities | |
| 23,540 | | |
| (49 | ) | |
| 23,491 | |
| Total liabilities | |
| 38,210 | | |
| (49 | ) | |
| 38,161 | |
| Additional paid-in capital | |
| 118,254 | | |
| 3,947 | | |
| 122,201 | |
| Accumulated deficit | |
| (152,214 | ) | |
| (3,898 | ) | |
| (156,112 | ) |
| Total stockholders’ deficit | |
$ | (33,960 | ) | |
$ | 49 | | |
$ | (33,911 | ) |
|
| Schedule of Company’s Condensed Consolidated Statements of Changes in Stockholders’ Deficit |
The following tables present the effects of the
aforementioned revisions on the Company’s condensed consolidated statements of operations and comprehensive loss for the three and nine
months ended September 30, 2025:
| | |
Three months ended
September 30, 2025 | | |
Nine months ended
September 30, 2025 | |
| | |
As previously
reported | | |
Adjustment | | |
As corrected | | |
As previously
reported | | |
Adjustment | | |
As
corrected | |
| Gain (loss) on change in the fair value of related party convertible debt | |
$ | 258 | | |
$ | (3,898 | ) | |
$ | (3,640 | ) | |
$ | (52 | ) | |
$ | (3,898 | ) | |
$ | (3,950 | ) |
| Total other expense, net | |
| (483 | ) | |
| (3,898 | ) | |
| (4,381 | ) | |
| (3,120 | ) | |
| (3,898 | ) | |
| (7,018 | ) |
| Net loss and comprehensive loss | |
| (22,192 | ) | |
| (3,898 | ) | |
| (26,090 | ) | |
| (27,256 | ) | |
| (3,898 | ) | |
| (31,154 | ) |
| Net loss per share, basic and diluted | |
$ | (52.45 | ) | |
$ | (9.22 | ) | |
$ | (61.67 | ) | |
$ | (171.70 | ) | |
$ | (24.56 | ) | |
$ | (196.26 | ) |
|
| Schedule of Company’s Condensed Consolidated Statements of Changes in Stockholders’ Deficit |
The following tables present the effects of the
aforementioned revisions on the Company’s condensed consolidated statements of changes in stockholders’ deficit for the three and nine
months ended September 30, 2025:
| | |
Three and nine months ended
September 30, 2025 | |
| | |
As previously
reported | | |
Adjustment | | |
As
corrected | |
| Issuance of common stock to Northview stockholders as a result of the merger | |
$ | (12,346 | ) | |
$ | 3,946 | | |
$ | (8,400 | ) |
|
| Schedule of Company’s Condensed Consolidated Statements of Cash Flows |
The following tables present the effects of the
aforementioned revisions on the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2025:
| | |
Nine months ended
September 30, 2025 | |
| | |
As previously
reported | | |
Adjustment | | |
As corrected | |
| Net loss | |
$ | (27,256 | ) | |
$ | (3,898 | ) | |
$ | (31,154 | ) |
| (Gain) Loss on change in fair value of related party convertible debt | |
| (198 | ) | |
| 3,898 | | |
| 3,700 | |
| Supplemental noncash financing information: Assumption of net liabilities of Northview | |
$ | (12,346 | ) | |
$ | 3,946 | | |
$ | (8,400 | ) |
|